| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Pyrimido[5,4-b]indolizine-4,8-diamine, 8,9-dihydro-6-methyl-5-(3-quinolinyl)-, (8S)- |
TAS6417中間體 |
1661855-22-6 |
詳細(xì)
|
| [1,2,4]Triazolo[1,5-a]pyridin-7-ol |
妥卡替尼中間體 |
1033810-70-6 |
詳細(xì)
|
| isopropanyl 2,4-dichloropyriMidine-5-carboxylate |
莫博替尼TAK788(AP32788)中間體 |
69312-43-2 |
詳細(xì)
|
| N'-(4-Amino-2-cyanophenyl)-N,N-dimethylformamidine |
妥卡替尼中間體 |
194423-17-1 |
詳細(xì)
|
| 3-Chloro-6-trifluoromethyl-pyridazine |
3-氯-6-三氟甲基噠嗪 |
258506-68-2 |
詳細(xì)
|
| Cabozantinib Malate |
蘋果酸卡博替尼（CABOZANTINIB S-MALATE） |
1140909-48-3 |
詳細(xì)
|
| Methyl 2-aMino-4-chloro-5-fluorobenzoate |
2-氨基-4-氯-5-氟苯甲酸甲酯 |
104901-79-3 |
詳細(xì)
|
| AMG-510 |
AMG-510(消旋體) |
2252403-56-6 |
詳細(xì)
|
| Toremifene citrate |
枸櫞酸托瑞米芬 |
89778-27-8 |
詳細(xì)
|
| Maropitant Citrate |
枸櫞酸馬羅匹坦 |
359875-09-5 |
詳細(xì)
|
| [1,2,4]Triazolo[1,5-a]pyridine, 7-(2-methyl-4-nitrophenoxy)- |
妥卡替尼中間體4 |
937263-44-0 |
詳細(xì)
|
| 6-FLUORO-IMIDAZO[1,2-B]PYRIDAZINE |
6-氟咪唑并[1,2-B]噠嗪 |
113501-27-2 |
詳細(xì)
|
| DZD9008 |
2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]- |
2370013-49-1 |
詳細(xì)
|
| Imidazo[1,2-b]pyridazine, 6-fluoro-, compd. with methanesulfonate (1:1) |
AB-106中間體 |
2244755-04-0 |
詳細(xì)
|
| 4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline |
妥卡替尼中間體(4-([1,2,4]三唑[1,5-A]吡啶-7-氧基)-3-甲基苯胺) |
937263-71-3 |
詳細(xì)
|
| Taletrectinib AB-106 |
他立替尼 AB-106 |
1505515-69-4 |
詳細(xì)
|
| 5-Pyrimidinecarboxylic acid, 2-chloro-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester |
莫博替尼 |
1847463-39-1 |
詳細(xì)
|
| TAK788(AP32788) |
TAK788(AP32788)琥珀酸 |
2389149-74-8 |
詳細(xì)
|
| 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile |
LOXO292中間體 |
1207836-10-9 |
詳細(xì)
|
| Tucatinib N-1 |
妥卡替尼中間體 |
1429755-58-7 |
詳細(xì)
|
| (E)-N'-(2-cyano-4-(3-(1-hydroxy-2-methylpropan-2-yl)thioureido)phenyl)-N,N-dimethylformimidamide |
妥卡替尼中間體8 |
1429755-57-6 |
詳細(xì)
|